| Vol. 14.27 – 21 July, 2023 |
| |
|
|
| The authors identified synaptotagmin-binding cytoplasmic RNA-interacting protein (SYNCRIP) as an endogenous molecular brake that suppressed APOBEC-driven mutagenesis in prostate cancer. [Cancer Cell] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers demonstrated that FTO-IT1 long noncoding RNA (lncRNA) was upregulated and positively correlated with poor survival of patients with wild-type p53-expressing prostate cancer. [Molecular Cell] |
|
|
|
| Scientists analyzed 24 circulating fatty acids in 2934 men, including 1431 prostate cancer cases and 1503 population controls from Ghana and the United States, using CLIA-certified mass spectrometry-based assays. [Nature Communications] |
|
|
|
| Investigators showed that spermine inhibited full-length androgen receptor (AR) and androgen receptor splice variant 7 signaling and suppressed castration-resistant prostate cancer cell proliferation by directly binding and inhibiting protein arginine methyltransferase protein arginine methyltransferases (PRMT) 1. [Cell Reports] |
|
|
|
| Scientists determined that lysine-specific demethylase 1 (LSD1) was highly upregulated in neuroendocrine prostate cancer (NEPC) vs. adenocarcinoma patient tumors. LSD1 suppression with RNAi or allosteric LSD1 inhibitors—but not catalytic inhibitors—reduced NEPC cell survival. [JCI Insight] |
|
|
|
| The authors performed a longitudinal study using their unique prostate cancer patient-derived xenograft models and assessed B7-H3 expression during post-androgen deprivation therapy (ADT) disease progression. [Cancer Gene Therapy] |
|
|
|
| Using the human prostate cancer cell line C4-2, investigators found that epidermal growth factor (EGF)-activated EGFR–ERK1/2 signaling via 3-O-sulfated heparan sulfate produced by HS 3-O-sulfotransferase 1 is activated in C4-2 cells under hormone depletion. [Scientific Reports] |
|
|
|
| Researchers developed a microphysiological system model comprising conventional prostate cancer cells to evaluate their activity under dynamic culture conditions. Androgen-sensitive and androgen-insensitive cells were grown in conventional and 3D cultures, both static and dynamic. [Scientific Reports] |
|
|
|
| Methyltransferase-like 3 (METTL3), miR-148a-3p, and thioredoxin interacting protein (TXNIP) levels were determined using RT-qPCR and Western blotting. The m6A modification level of miR-148a-3p was observed by Me-RIP assay. [Environmental Toxicology] |
|
|
|
|
| Scientists highlight the current in vitro 3D prostate cancer (PCa) models with a special focus on organoids and discuss engineering approaches to create more physiologically relevant PCa organoid models. [Oncogene] |
|
|
|
| The authors summarize the definition and classification of oligometastatic prostate cancer, assess the diagnostic methods and imaging modalities utilized, and review the treatment options and outcomes. [Prostate Cancer and Prostatic Diseases] |
|
|
|
|
| Ambrx Biopharma Inc. announced that the U.S. FDA has granted Fast Track designation to Ambrx’s proprietary anti-PSMA antibody-drug conjugate investigational therapy, ARX517, for the treatment of patients with metastatic castration-resistant prostate cancer. [Ambrx Biopharma Inc.] |
|
|
|
|
| September 13 – 15, 2023 Seogwipo, South Korea |
|
|
|
|
|
| Moffitt Cancer Center – Tampa, Florida, United States |
|
|
|
| Washington University – St. Louis, Missouri, United States |
|
|
|
| Albert Einstein College of Medicine – New York City, New York, United States |
|
|
|
| University of Miami – Miami, Florida, United States |
|
|
|
| NCI Center for Cancer Research – Bethesda, Maryland, United States |
|
|
|
|